3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Carcinoma, Transitional Cell
1
Interventions
Specimen Handling
483
pembrolizumab
456
Magnetic Resonance Spectroscopy
420
Carboplatin
327
Cyclophosphamide
315
Biopsy
274
Cisplatin
270
Radiotherapy
244
Paclitaxel
229
Gemcitabine
225
Bevacizumab
214
Nivolumab
189
fludarabine
184
venetoclax
174
Drug Therapy
171
Dexamethasone
158
Blood Specimen Collection
158
Oxaliplatin
154
Injections
152
Capecitabine
152
Fluorouracil
145
Docetaxel
144
Radiosurgery
137
Standard of Care
136
Rituximab
125
Pemetrexed
117
durvalumab
114
atezolizumab
110
Leucovorin
110
Radiation
106
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
tamibarotene
×
1 year
×
Clear all
NCT06983210
2025-08-14
GRAPE
Nagoya University
Phase 2
Recruiting
43 enrolled